Back to Search

JAMES MOSLEY, MD

MD

Hematology & Oncology Physician

NPI: 1518090125IndividualAccepts Medicare

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

2006008795(MO)

CMS Specialties

PrimaryMEDICAL ONCOLOGY

Additional

HEMATOLOGY

Education

UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE

Class of 2003

Research & Publications (20)

The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.
PMID 18184195·J Viral Hepat·2008
8-other
Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists.
PMID 18439262·BMC Med Genomics·2008
8-other
The problem surgical colleague.
PMID 17688714·Ann R Coll Surg Engl·2007
6-review
Viral and host factors in early hepatitis C virus infection.
PMID 15954090·Hepatology·2005
8-other
Arterial problems in athletes.
PMID 14648723·Br J Surg·2003
6-review
Growth rate rather than gender determines the size of the adaptive response of the growing skeleton to mechanical strain.
PMID 11792603·Bone·2002
4-observational
Relationship between skin color and blood pressure in egyptian adults: results from the national hypertension project.
PMID 10948093·Hypertension·2000
8-other
Second generation of BACE-1 inhibitors part 3: Towards non hydroxyethylamine transition state mimetics.
PMID 19406640·Bioorg Med Chem Lett·2009
7-preclinical
Lack of evidence for human herpesvirus-8 transmission via blood transfusion in a historical US cohort.
PMID 19385734·J Infect Dis·2009
8-other
Intrinsic bias in breast cancer gene expression data sets.
PMID 19563679·BMC Cancer·2009
8-other
Genetic selection for fast growth generates bone architecture characterised by enhanced periosteal expansion and limited consolidation of the cortices but a diminution in the early responses to mechanical loading.
PMID 19409517·Bone·2009
7-preclinical
Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics.
PMID 19428244·Bioorg Med Chem Lett·2009
7-preclinical
Second generation of BACE-1 inhibitors part 2: Optimisation of the non-prime side substituent.
PMID 19477642·Bioorg Med Chem Lett·2009
7-preclinical
1-Aryl-3,4-dihydroisoquinoline inhibitors of JNK3.
PMID 19303774·Bioorg Med Chem Lett·2009
4-observational
BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic character.
PMID 18166458·Bioorg Med Chem Lett·2008
8-other
BACE-1 inhibitors part 1: identification of novel hydroxy ethylamines (HEAs).
PMID 18171614·Bioorg Med Chem Lett·2008
8-other
BACE-1 inhibitors part 3: identification of hydroxy ethylamines (HEAs) with nanomolar potency in cells.
PMID 18171615·Bioorg Med Chem Lett·2008
7-preclinical
Clinical and neurological characteristics of aortic thromboembolism in dogs.
PMID 18339088·J Small Anim Pract·2008
7-preclinical
Second generation of hydroxyethylamine BACE-1 inhibitors: optimizing potency and oral bioavailability.
PMID 18457381·J Med Chem·2008
7-preclinical
Costs of additional cover.
PMID 18831875·Ann R Coll Surg Engl·2008
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
789 S MOUNT AUBURN RD, DEPT. OF MEDICINE
CAPE GIRARDEAU, MO 63703

Location

Practice Location

789 S MOUNT AUBURN RD, CAPE GIRARDEAU, MO
(573) 519-4830

Quick Facts

NPI
1518090125
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
23
Publications
20

Are you this provider?

Claim Your Profile